Access the full text.
Sign up today, get DeepDyve free for 14 days.
E.J. Benjamin (2017)
e146Circulation, 135
I. Kutyrev, Frederik Franke, J. Büscher, J. Kurtz, J. Scharsack (2014)
In vitro effects of prostaglandin E2 on leucocytes from sticklebacks (Gasterosteus aculeatus) infected and not infected with the cestode Schistocephalus solidus.Fish & shellfish immunology, 41 2
Heart disease and stroke statistics — 2017 update : A report from the American Heart Association , Circulation
Sung Park, H. Chun, C. Kang, D. Sul (2011)
Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury.World journal of gastroenterology, 17 42
G. Gislason, S. Jacobsen, J. Rasmussen, S. Rasmussen, P. Buch, J. Friberg, T. Schramm, S. Abildstrom, L. Køber, M. Madsen, C. Torp-Pedersen (2006)
Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial InfarctionCirculation, 113
(2008)
The use of mexidol to optimize the treatment of arterial hypertension in young people
E. Ivanova, A. Matyushkin, A. Vasilchuk, T. Voronina (2021)
Effect of Cyclooxygenase Inhibitors Etoricoxib and Diclofenac Sodium and Their Combinations with Mexidol on Behavior in RatsMoscow University Biological Sciences Bulletin, 76
C. Cannon, S. Curtis, G. FitzGerald, H. Krum, A. Kaur, J. Bolognese, A. Reicin, C. Bombardier, M. Weinblatt, D. Heijde, E. Erdmann, L. Laine (2006)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparisonThe Lancet, 368
P. Fortun, C. Hawkey (2005)
Nonsteroidal antiinflammatory drugs and the small intestineCurrent Opinion in Gastroenterology, 21
G. FitzGerald (2004)
Coxibs and cardiovascular disease.The New England journal of medicine, 351 17
I. Danelich, Sampaguita Wright, Jennifer Lose, Brittany Tefft, Jonathan Cicci, Brent Reed (2015)
Safety of Nonsteroidal Antiinflammatory Drugs in Patients with Cardiovascular DiseasePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 35
E. Ivanova, A. Matyushkin, A. Vasilchuk, T. Voronina (2021)
Ability of Mexidol to Enhance Antiexudative Effect of Diclofenac Sodium and Etoricoxib in Rats and Mice with Carrageenan-Induced EdemaMoscow University Biological Sciences Bulletin, 76
Y. Lim, C. Yang (2012)
Non-Steroidal Anti-Inflammatory Drug-Induced EnteropathyClinical Endoscopy, 45
J. Schwartz, C. Thach, K. Lasseter, Jutta Miller, D. Hreniuk, D. Hilliard, K. Snyder, B. Gertz, K. Gottesdiener (2007)
Effects of Etoricoxib and Comparator Nonsteroidal Anti‐Inflammatory Drugs on Urinary Sodium Excretion, Blood Pressure, and Other Renal Function Indicators in Elderly Subjects Consuming a Controlled Sodium DietThe Journal of Clinical Pharmacology, 47
Guillherme Lucas, Ana Leitão, Renan Alencar, R. Xavier, E. Daher, G. Júnior (2018)
Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugsJornal Brasileiro de Nefrologia, 41
(2009)
Mexidol: main neuropsychotropic effects and mechanism of action
E. Andrès, F. Maloisel (2008)
Idiosyncratic drug-induced agranulocytosis or acute neutropeniaCurrent Opinion in Hematology, 15
D. Mukherjee, S. Nissen, E. Topol (2001)
Risk of cardiovascular events associated with selective COX-2 inhibitors.JAMA, 286 8
P.J. Fortun (2007)
134Curr. Opin. Gastroenterol, 23
D. Graham, A. Opekun, F. Willingham, W. Qureshi (2005)
Visible small-intestinal mucosal injury in chronic NSAID users.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 3 1
—The effect on blood pressure (BP), hematological indices, and body weight of rats was evaluated for nonselective cyclooxygenase (COX) inhibitor diclofenac sodium (1 and 5 mg/kg) and selective COX-2 inhibitor etoricoxib (1 and 10 mg/kg), 2-ethyl-6-methyl-3-hydroxypyridine succinate (mexidol, 25 mg/kg) and combinations of these nonsteroidal anti-inflammatory drugs (NSAIDs, 1 mg/kg) with mexidol administered per os as a 2- and 3-week daily course. BP increase was observed in rats after 3 weeks of NSAID administration. Specifically, etoricoxib at both doses increased the systolic and diastolic pressures, while diclofenac sodium at a dose of 5 mg/kg only affected the diastolic pressure. Mexidol prevented the BP increase when taken together with etoricoxib. The administration of NSAIDs at maximum doses for 2 weeks was associated with an increase in certain leukocyte type counts. Furthermore, diclofenac sodium increased the number of platelets and induced iron-deficiency anemia, indicating the NSAID-induced enteropathy. Both NSAIDs were shown to negatively affect the dynamics of weight gain in rats, with diclofenac sodium having a more pronounced effect. The combination of diclofenac sodium and etoricoxib with mexidol did not enhance the negative effects of NSAIDs on hematological parameters and weight gain in rats.
Moscow University Biological Sciences Bulletin – Springer Journals
Published: Mar 1, 2022
Keywords: diclofenac sodium; etoricoxib; mexidol; blood pressure; hematological indices; rats
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.